{
    "organizations": [],
    "uuid": "b6098da7b9eb51f5f662697a3e4cd9cf1145e2df",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-isr-holding-starts-new-subsidiary/brief-isr-holding-starts-new-subsidiary-idUSFWN1R8024",
    "ord_in_thread": 0,
    "title": "BRIEF-ISR Holding Starts New Subsidiary",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL):\n* ISR HOLDING STARTS A NEW SUBSIDIARY - ISR ONCOLOGY AB\n* ‍25 DECIDED TO FORM A SUBSIDIARY WITH A FOCUS ON CANCER TREATMENT.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-26T14:10:00.000+03:00",
    "crawled": "2018-03-27T11:51:17.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "isr",
        "immune",
        "system",
        "regulation",
        "holding",
        "ab",
        "publ",
        "isr",
        "holding",
        "start",
        "new",
        "subsidiary",
        "isr",
        "oncology",
        "ab",
        "decided",
        "form",
        "subsidiary",
        "focus",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}